Biotalys receives product registration in California for EVOCA

The approval follows the successful completion of the public consultation process earlier in July and confirms Biotalys' biofungicide EVOCA has successfully met the state's stringent regulatory requirements for human health, environmental safety and product efficacy.

A logo with white text on a green background reads Biotalys: reinventing food protection.

Logo courtest of Biotalys

Biotalys, an agricultural technology company developing protein-based biocontrols for sustainable crop protection, announced that the California Department of Pesticide Regulation has granted state registration for EVOCA, the company's first protein-based biofungicide.

EVOCA is a protein-based AGROBODY biocontrol that helps control the fungal diseases Botrytis (grey mold) and powdery mildew for fruit and vegetable growers.

The approval follows the successful completion of the public consultation process earlier in July and confirms that EVOCA has successfully met the state's stringent regulatory requirements for human health, environmental safety and product efficacy.

"California is widely recognized for applying some of the world's most rigorous requirements to crop protection products," Biotalys said in a news release. "Securing approval therefore provides meaningful validation of EVOCA and the underlying AGROBODY platform that supports Biotalys' pipeline."

"This California registration is an important achievement for Biotalys," said Biotalys CEO Carlo Boutton. "Meeting the state's demanding scientific and regulatory standards underscores the potential of our AGROBODY biocontrols, an entirely new class of protein-based crop protection solutions. Our ambition is to offer growers novel, safe and effective biological products that help them protect their crops and produce food more sustainably.

"EVOCA NG is one of the lead assets in our refocused strategy and is expected to become our first commercial product," Boutton continued. "As it is based on the same active ingredient and AGROBODY foundation as EVOCA, the California decision is highly relevant to its further development. It strengthens our confidence in bringing EVOCA NG to U.S. growers in 2029 and gives shareholders greater visibility on our commercialization pathway and the long-term potential of our platform and pipeline."

The product was registered in Florida earlier this year and received prior regulatory approval from the U.S. Environmental Protection Agency.

Regulatory review is ongoing in the European Union. An approval of EVOCA paves the way for the regulatory submission of EVOCA NG, the product’s next generation version containing the same active ingredient.

EVOCA NG is expected to be Biotalys’ first commercial biofungicide, with a planned launch in the U.S. in 2029 and in Europe in 2030.

No more results found.
No more results found.
Switch Website: Greenhouse Management